FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3138291983> ?p ?o ?g. }

• W3138291983 endingPage "1420" @default.
• W3138291983 startingPage "1410" @default.
• W3138291983 abstract "The EXPAND Study demonstrated the effectiveness and safety of rivaroxaban in patients with non-valvular atrial fibrillation (NVAF) in routine clinical practice in Japan. This sub-analysis was conducted to reveal the effectiveness and safety of rivaroxaban in Japanese NVAF patients according to baseline creatinine clearance (CrCl) levels and rivaroxaban doses in the EXPAND Study. We examined 6806 patients whose baseline CrCl data were available and classified them into 2 groups: normal renal function group with CrCl ≥ 50 mL/min (n = 5326, 78%) and renal dysfunction group with CrCl < 50 mL/min (n = 1480, 22%). In the normal renal function group, 1609 (30%) received 10 mg/day (under-dose), while in the renal dysfunction group, 108 (7%) received 15 mg/day (over-dose). In the normal renal function group, under-dose of rivaroxaban was associated with higher all-cause mortality, while in the renal dysfunction group, over-dose was associated with higher incidence of major bleeding. In contrast, the incidence of stroke or systemic embolism was not different between the 2 groups regardless of the dose of rivaroxaban. In the propensity score matched analysis to adjust the difference in characteristics according to doses of rivaroxaban, the incidences of clinical outcomes were comparable between the 2 dose groups in both renal function groups. These results indicate that the dose of rivaroxaban should be reduced depending on the renal function, considering the balance between risks of bleeding and ischemia." @default.
• W3138291983 created "2021-03-29" @default.
• W3138291983 creator A5009147715 @default.
• W3138291983 creator A5012657143 @default.
• W3138291983 creator A5021449876 @default.
• W3138291983 creator A5025141510 @default.
• W3138291983 creator A5030012941 @default.
• W3138291983 creator A5031249539 @default.
• W3138291983 creator A5052029560 @default.
• W3138291983 creator A5055983723 @default.
• W3138291983 creator A5067341497 @default.
• W3138291983 creator A5072169946 @default.
• W3138291983 creator A5073598073 @default.
• W3138291983 creator A5079485654 @default.
• W3138291983 date "2021-03-16" @default.
• W3138291983 modified "2023-09-29" @default.
• W3138291983 title "Ischemic stroke, hemorrhage, and mortality in patients with non-valvular atrial fibrillation and renal dysfunction treated with rivaroxaban: sub-analysis of the EXPAND study" @default.
• W3138291983 cites W1550111394 @default.
• W3138291983 cites W1984553148 @default.
• W3138291983 cites W2018856451 @default.
• W3138291983 cites W2034802660 @default.
• W3138291983 cites W2038686643 @default.
• W3138291983 cites W2054077136 @default.
• W3138291983 cites W2062786076 @default.
• W3138291983 cites W2068568996 @default.
• W3138291983 cites W2092492353 @default.
• W3138291983 cites W2097854437 @default.
• W3138291983 cites W2114775432 @default.
• W3138291983 cites W2117807413 @default.
• W3138291983 cites W2125791343 @default.
• W3138291983 cites W2148984742 @default.
• W3138291983 cites W2160965212 @default.
• W3138291983 cites W2195719407 @default.
• W3138291983 cites W2216123836 @default.
• W3138291983 cites W2320128544 @default.
• W3138291983 cites W2334781704 @default.
• W3138291983 cites W2418657516 @default.
• W3138291983 cites W2469001618 @default.
• W3138291983 cites W2557708440 @default.
• W3138291983 cites W2561745040 @default.
• W3138291983 cites W2582523257 @default.
• W3138291983 cites W2786585951 @default.
• W3138291983 cites W2788040427 @default.
• W3138291983 cites W2789831746 @default.
• W3138291983 cites W2792857103 @default.
• W3138291983 cites W2848183888 @default.
• W3138291983 cites W2874581678 @default.
• W3138291983 cites W2897070363 @default.
• W3138291983 cites W2914431396 @default.
• W3138291983 cites W2969817746 @default.
• W3138291983 cites W2989714602 @default.
• W3138291983 cites W3082179368 @default.
• W3138291983 cites W3086493071 @default.
• W3138291983 cites W4238531734 @default.
• W3138291983 cites W4292143351 @default.
• W3138291983 doi "https://doi.org/10.1007/s00380-021-01810-5" @default.
• W3138291983 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8332581" @default.
• W3138291983 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33728513" @default.
• W3138291983 hasPublicationYear "2021" @default.
• W3138291983 type Work @default.
• W3138291983 sameAs 3138291983 @default.
• W3138291983 citedByCount "10" @default.
• W3138291983 countsByYear W31382919832021 @default.
• W3138291983 countsByYear W31382919832022 @default.
• W3138291983 countsByYear W31382919832023 @default.
• W3138291983 crossrefType "journal-article" @default.
• W3138291983 hasAuthorship W3138291983A5009147715 @default.
• W3138291983 hasAuthorship W3138291983A5012657143 @default.
• W3138291983 hasAuthorship W3138291983A5021449876 @default.
• W3138291983 hasAuthorship W3138291983A5025141510 @default.
• W3138291983 hasAuthorship W3138291983A5030012941 @default.
• W3138291983 hasAuthorship W3138291983A5031249539 @default.
• W3138291983 hasAuthorship W3138291983A5052029560 @default.
• W3138291983 hasAuthorship W3138291983A5055983723 @default.
• W3138291983 hasAuthorship W3138291983A5067341497 @default.
• W3138291983 hasAuthorship W3138291983A5072169946 @default.
• W3138291983 hasAuthorship W3138291983A5073598073 @default.
• W3138291983 hasAuthorship W3138291983A5079485654 @default.
• W3138291983 hasBestOaLocation W31382919831 @default.
• W3138291983 hasConcept C120665830 @default.
• W3138291983 hasConcept C121332964 @default.
• W3138291983 hasConcept C126322002 @default.
• W3138291983 hasConcept C127413603 @default.
• W3138291983 hasConcept C159641895 @default.
• W3138291983 hasConcept C164705383 @default.
• W3138291983 hasConcept C2776301958 @default.
• W3138291983 hasConcept C2777185221 @default.
• W3138291983 hasConcept C2778661090 @default.
• W3138291983 hasConcept C2779161974 @default.
• W3138291983 hasConcept C2780306776 @default.
• W3138291983 hasConcept C2780645631 @default.
• W3138291983 hasConcept C42219234 @default.
• W3138291983 hasConcept C61511704 @default.
• W3138291983 hasConcept C71924100 @default.
• W3138291983 hasConcept C78519656 @default.
• W3138291983 hasConceptScore W3138291983C120665830 @default.
• W3138291983 hasConceptScore W3138291983C121332964 @default.
• W3138291983 hasConceptScore W3138291983C126322002 @default.

• next